Kevin Bitterman Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Kevin Bitterman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Kevin Bitterman. Kevin Bitterman is Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and Director in Editas Medicine, Inc. ($EDIT) and Director in Akero Therapeutics, Inc. ($AKRO).
Latest Insider Trading Transactions of Kevin Bitterman
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AKRO, EDIT, GNCA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 14 2020 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Sell | S | 28.93 | 13,000 | 376,090 | 11,780 | 24.8 K to 11.8 K (-52.46 %) |
| Jun 02 2020 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Option Exercise | A | 25.20 | 13,000 | 327,600 | 13,000 | |
| Nov 12 2019 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Option Exercise | A | 19.97 | 26,000 | 519,220 | 26,000 | |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 722,737 | 0 | 0 | |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 10,666,667 | 0 | 0 | |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Buy | P | 16.00 | 270,000 | 4,320,000 | 505,099 | 235.1 K to 505.1 K (+114.85 %) |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Buy | C | 0.00 | 235,099 | 0 | 235,099 | 0 to 235.1 K |
| Jun 25 2019 | AKRO | Akero Therapeutics ... | Bitterman Kevin | Director | Buy | C | 0.00 | 3,469,759 | 0 | 3,469,759 | 0 to 3.5 M |
| Jun 19 2017 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Option Exercise | A | 15.63 | 11,538 | 180,339 | 11,538 | |
| May 24 2017 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 17.00 | 1,000,000 | 17,000,000 | 2,797,144 | 3.8 M to 2.8 M (-26.34 %) |
| Dec 08 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 15.82 | 75,000 | 1,186,500 | 3,797,144 | 3.9 M to 3.8 M (-1.94 %) |
| Dec 07 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 15.87 | 50,000 | 793,500 | 3,872,144 | 3.9 M to 3.9 M (-1.27 %) |
| Dec 07 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 15.74 | 80,000 | 1,259,200 | 3,922,144 | 4 M to 3.9 M (-2.00 %) |
| Nov 28 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 15.71 | 21,480 | 337,451 | 4,002,144 | 4 M to 4 M (-0.53 %) |
| Nov 23 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 15.77 | 12,819 | 202,156 | 4,023,624 | 4 M to 4 M (-0.32 %) |
| Nov 18 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 16.30 | 30,830 | 502,529 | 4,036,443 | 4.1 M to 4 M (-0.76 %) |
| Nov 16 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 17.78 | 498 | 8,854 | 4,067,273 | 4.1 M to 4.1 M (-0.01 %) |
| Nov 16 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 16.55 | 30,367 | 502,574 | 4,067,771 | 4.1 M to 4.1 M (-0.74 %) |
| Nov 16 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 17.16 | 58,035 | 995,881 | 4,098,138 | 4.2 M to 4.1 M (-1.40 %) |
| Sep 12 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Sell | S | 16.80 | 500,000 | 8,400,000 | 4,156,173 | 4.7 M to 4.2 M (-10.74 %) |
| Jun 07 2016 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | A | 4.64 | 15,000 | 69,600 | 15,000 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 222,222 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 5,255,300 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 6,628,542 | 0 | 0 | |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Buy | C | 0.00 | 85,469 | 0 | 4,656,173 | 4.6 M to 4.7 M (+1.87 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Buy | C | 0.00 | 2,021,269 | 0 | 4,570,704 | 2.5 M to 4.6 M (+79.28 %) |
| Feb 09 2016 | EDIT | Editas Medicine, I ... | Bitterman Kevin | Director | Buy | C | 0.00 | 2,549,435 | 0 | 2,549,435 | 0 to 2.5 M |
| Mar 02 2015 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | A | 9.08 | 5,042 | 45,781 | 5,042 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | X | 0.00 | 399,909 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 6,075,152 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 5,836,663 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 8,393,754 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Option Exercise | C | 0.00 | 2,126,923 | 0 | 0 | |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | P | 12.00 | 232,820 | 2,793,840 | 2,128,678 | 1.9 M to 2.1 M (+12.28 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 10,781 | 0 | 1,895,858 | 1.9 M to 1.9 M (+0.57 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 510,516 | 0 | 1,885,077 | 1.4 M to 1.9 M (+37.14 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 490,474 | 0 | 1,374,561 | 884.1 K to 1.4 M (+55.48 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 705,356 | 0 | 884,087 | 178.7 K to 884.1 K (+394.65 %) |
| Feb 11 2014 | GNCA | GENOCEA BIOSCIENCE ... | Bitterman Kevin | Director | Buy | C | 0.00 | 178,731 | 0 | 178,731 | 0 to 178.7 K |
Page: 1